Editas Medicine所有资讯

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(5.58%)

07/10 06:29 (美东)

Editas Medicine | 4：持股变动声明-高管 O'Neill Gilmore Neil

06/06 16:22 (美东)

Editas Medicine | 4：持股变动声明-高管 Mei Baisong

06/06 16:17 (美东)

Editas Medicine | 4：持股变动声明-董事 Scadden David

06/03 17:23 (美东)

Editas Medicine | 4：持股变动声明-董事 Chatterjee Meeta

06/03 17:21 (美东)

Editas Medicine | 4：持股变动声明-董事 Hopfield Jessica

06/03 17:20 (美东)

Editas Medicine | 4：持股变动声明-董事 Hirsch Andrew

06/03 17:17 (美东)

Editas Medicine | 4：持股变动声明-董事 Connaughton Bernadette

06/03 16:40 (美东)

Editas Medicine | 4：持股变动声明-董事 Vaishnaw Akshay

06/03 16:35 (美东)

Editas Medicine | 4：持股变动声明-董事 Reeve Emma

06/03 16:34 (美东)

Editas Medicine | 4：持股变动声明-董事 Levy Elliott M.

06/03 16:33 (美东)

Editas Medicine | 4：持股变动声明-高管 Lucera Erick

05/22 16:35 (美东)

Editas Medicine | 4：持股变动声明-董事 Hopfield Jessica

05/14 16:24 (美东)

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(10.71%),SSGA FUNDS MANAGEMENT, INC.(8.50%)

04/10 09:42 (美东)

Editas Medicine | 4：持股变动声明-高管 Lucera Erick

03/05 20:09 (美东)

Editas Medicine | 4：持股变动声明-高管 Burkly Linda

03/05 20:09 (美东)

Editas Medicine | 4：持股变动声明-高管 O'Neill Gilmore Neil

03/05 20:05 (美东)

Editas Medicine | 4：持股变动声明-高管 Mei Baisong

03/05 19:59 (美东)

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%)等

02/14 08:42 (美东)

Editas Medicine | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(10.36%)

02/13 18:06 (美东)